Form 4: Morgan Stanley Co-President Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Morgan Stanley Co-President Andrew M. Saperstein sold 30,330 shares of common stock through pre-arranged transactions.
Summary
- Andrew M. Saperstein, Co-President of Morgan Stanley, disposed of a total of 30,330 shares of Morgan Stanley common stock.
- The sales occurred on January 20, 2026, across six separate transactions.
- The shares were sold at weighted average prices ranging from $181.8518 to $186.596 per share.
- These transactions were executed pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
- Following these reported transactions, Saperstein directly beneficially owns 280,480.994 shares of Morgan Stanley common stock.
Sentiment
Score: 5
Explanation: The sale of shares by a Co-President is generally viewed as a slight negative, but the fact that it was executed under a Rule 10b5-1 plan mitigates the negative sentiment, making it a more neutral event as it was pre-scheduled and not based on new material non-public information.
Positives
- The transactions were conducted under a Rule 10b5-1(c) plan, which indicates pre-scheduled sales and not necessarily a new negative outlook on the company.
Negatives
- An insider, the Co-President, sold a significant number of shares (30,330 shares) of company stock.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may interpret the sale as a slight negative signal, though the 10b5-1 plan context reduces this concern as it indicates a pre-planned transaction rather than a reaction to new information.
Key Dates
| Date | Description |
|---|---|
| 01/20/2026 | Date of earliest transaction (multiple sales of common stock by Andrew M. Saperstein) |
| 01/22/2026 | Signature date of the reporting person's attorney-in-fact for the filing |
Recommendation
holdThe sale of shares by a Co-President, while a reduction in insider ownership, was executed under a pre-arranged Rule 10b5-1 plan. This suggests a planned diversification or liquidity event rather than a reaction to new negative company-specific information. Therefore, this filing alone does not warrant a change in investment thesis, and a 'hold' recommendation is appropriate.
Keywords
Morgan Stanley, MS, Insider Trading, Form 4, Andrew M. Saperstein, Stock Sale, Co-President, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.